Related Experiment Video
Updated: Dec 6, 2025
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
5.2K
Preventing and Treating Anthracycline Cardiotoxicity: New Insights
Konrad Teodor Sawicki1, Valentina Sala2, Lorenzo Prever2
1Division of Cardiology, Feinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA;
Annual Review of Pharmacology and Toxicology
|October 6, 2020
Summary
Anthracycline chemotherapy can cause heart damage (cardiotoxicity) that limits its use. This review explores recent advances in understanding and managing this serious side effect.
Area of Science:
- Oncology
- Cardiology
- Pharmacology
Background:
- Anthracyclines are vital chemotherapy drugs for many cancers.
- Their clinical utility is restricted by dose-dependent cardiotoxicity.
- The precise mechanisms of anthracycline-induced heart damage remain incompletely understood after decades of research.
Purpose of the Study:
- To review the current understanding of anthracycline cardiotoxicity.
- To discuss incidence, risk factors, clinical presentation, and pathophysiology.
- To summarize recent advances in molecular mechanisms and management strategies.
Main Methods:
- Comprehensive literature review of anthracycline cardiotoxicity.
- Analysis of epidemiological data, clinical studies, and preclinical research.
- Synthesis of findings on molecular pathways and therapeutic interventions.
Main Results:
- Anthracycline cardiotoxicity presents with varied clinical manifestations.
- Multiple molecular mechanisms contribute to heart muscle damage.
- Recent research has elucidated novel pathways involved in cardiotoxicity.
- Preventive and therapeutic strategies are evolving.
Conclusions:
- Understanding anthracycline cardiotoxicity is crucial for optimizing cancer treatment.
- Continued research into molecular mechanisms is key to developing safer therapies.
- Multidisciplinary approaches are needed for effective prevention and management.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
176
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
231
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
231
01:29Cardiomyopathy VI: Nursing Management
196
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
196
01:30Cardiomyopathy II: Dilated Cardiomyopathy
270
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
270
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
164
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
164
01:20Exercise and Cardiovascular Response
3.6K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.6K